Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) and BeiGene (NASDAQ:BGNE – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends. Profitability This table compares Sagimet Biosciences […]
Sagimet Biosciences Inc Series A (NASDAQ:SGMT) Announces Earnings Results themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sagimet Biosciences Inc Series A s Quiet Period Set To End Tomorrow (NASDAQ:SGMT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sagimet Biosciences Inc. Series A’s (NASDAQ:SGMT – Get Free Report) quiet period is set to end on Wednesday, August 23rd. Sagimet Biosciences Inc. Series A had issued 5,312,500 shares in its public offering on July 14th. The total size of the offering was $85,000,000 based on an initial share price of $16.00. During the company’s […]
Piper Sandler started coverage on shares of Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Free Report) in a research report sent to investors on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $67.00 target price on the stock. SGMT has been the topic of a number of other research reports. […]